Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Rang in Aktien #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Aktienkurs
$0.32276013
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$25.60M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-37.52%
Land
TW
Handel MegaPro Biomedical Co., Ltd (6827)

Kategorie

Kursverlauf für MegaPro Biomedical Co., Ltd (6827)
Höchster Schlusskurs: $0.32 am 2026-08-01

Niedrigster Schlusskurs: $1.16 am 2021-10-01
Kursverlauf der Aktie von MegaPro Biomedical Co., Ltd von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 5.43%
2025 -10.48%
2024 -45.13%
2023 34.29%
2022 -46.18%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.05 -14.77%
AU
$753.28 5.84%
CH